Long-term Outcome comparing Histological Grades of Follicular Lymphoma Patients Treated with Immunochemotherapy as First Line Therapy. A Retrospective Analysis from Two Institutions".
To clarify the impact of histological grades in Follicular Lymphoma. we retrospectively analysed 250 patients diagnosed with FL treated with chemoimmunotherapy: 188 patients were grade 1-2 and 62 grades 3A. in our series, grade 3A FL patients were older, higher proportion of localized disease and lower bone marrow infiltration at diagnosis comparing grade 1-2 FL patients. Estimated six-year progression free survival and time to progression showed no differences between both groups [grade 3A: 56% (95%CI: 39-73%) and 51% (95%CI: 41-61%) vs. grade 1-2: 55% (95%CI: 46-63%) and 57% (95%CI: 49-65%), p=0.782 and p=0.521, respectively]. Estimated six-year overall survival was lower, 76% (95%CI: 64-88%) for the grade 3A group than grade 1-2 83% (95%CI: 77-89%); p=0.044. In addition to that, cumulative incidence curves of death not related to lymphoma at 10 years between groups were as follows: [0.26 (95%CI: 0.25-0.27) and 0.05 (95%CI: 0.04-0.06) for G3AFL and G1-2FL, respectively], p=0.010. Grade 3A FL showed in PFS curve no relapses after 6 years. These results were absolutely reproduced in 199 patients receiving R-CHOP regimen as induction. Our results indicate similar long-term outcomes in terms of progression free-survival and time to progression in grades 1-2 and 3A. No relapses were observed in G3AFL group after 6 years.